Live Updates

Full Federal Court dismisses ASIC appeal against former Freedom Insurance director

AI Analysis

The Full Federal Court dismissed ASIC’s appeal concerning former Freedom Insurance director Keith Cohen, but held that Freedom’s sales incentives—including Bali trips and a Vespa reward linked to sales performance—were conflicted remuneration under the Corporations Act 2001 (Cth). The decision separates classification of an incentive arrangement from personal liability: ASIC did not establish that Cohen was knowingly involved in a contravention or breached his directors’ duty under section 180(1), making the judgment important for both remuneration controls and enforcement strategy.

Key dates

2017-11-01
Approximate start of the Freedom Group sales incentive programs examined in the proceedings.
2018-10-31
Approximate end of the Freedom Group sales incentive programs examined in the proceedings.
2020-01-01
Life Insurance Framework-related conflicted remuneration restrictions had commenced before the end of the relevant historical period; firms should assess applicable transitional and product-specific rules for arrangements operating around this date.
2021-10-01
ASIC commenced civil penalty proceedings against Keith Cohen and Robert Oayda.
2025-10-16
The Federal Court dismissed ASIC’s claims against Cohen and Oayda.
2025-11-11
ASIC filed its appeal against the Federal Court decision.
2025-12-19
ASIC’s appeal concerning Robert Oayda was withdrawn by consent.
2026-08-26
The Full Federal Court hearing of ASIC’s appeal commenced; the hearing ran on 26 and 27 August 2026.

Suggested considerations

  • Firms should inventory cash and non-cash sales incentives paid or offered in connection with financial product advice, including competitions, travel, prizes, bonuses and volume-based targets.
  • Compliance teams may wish to assess each arrangement against the definition of conflicted remuneration in section 963A and the prohibitions in sections 963E and 963F of the Corporations Act, including whether the benefit could reasonably be expected to influence the choice of financial product or the advice provided.
  • Firms should document whether relevant sales personnel provide financial product advice and retain evidence supporting that assessment, because the advice element can be material to application of the regime.
  • Insurers and licensees should consider testing whether incentive design prioritises sales volume over customer needs and whether controls address the post-Life Insurance Framework environment, including the restrictions introduced from 1 January 2020.
  • Boards and senior managers may wish to document responsibility for conflicted-remuneration compliance, escalation processes, legal advice, risk review and monitoring, while avoiding treating delegation as a substitute for effective oversight.
  • Firms should review remuneration governance, management information and assurance testing for legacy and current incentive schemes, particularly where rewards are linked to policy sales, cancellations, persistency or product selection.
  • Compliance teams may wish to review the Full Federal Court judgment and related legal commentary with counsel before relying on the decision to support any particular incentive arrangement; the dismissal of ASIC’s claim against Cohen does not make comparable incentives permissible.

What changed

No new legislation, transitional period or filing requirement was introduced. The judgment clarifies that sales incentives may fall within the conflicted remuneration regime in Part 7.7A of the Corporations Act even where the regulator cannot ultimately establish personal liability for a director or officer. The decision also indicates that a finding that an arrangement is conflicted remuneration does not automatically prove that an individual was knowingly involved in a contravention or failed to exercise reasonable care and diligence under section 180(1). Independent commentary highlights the evidentiary distinction between proving the underlying corporate contravention and proving an individual’s involvement, as well as the relevance of documented allocation of compliance responsibiliti

Compliance impact

The decision is a significant conduct and governance signal for insurance distributors and AFSL holders, although it does not impose a new compliance obligation or penalty. The underlying incentive classification remains adverse, while the outcome against Cohen shows that ASIC must separately prove individual involvement and, for section 180(1), a failure to take the care and diligence reasonably

Who is affected

  • Australian financial services licensees distributing life and other insurance products
  • Insurers and insurance distributors using sales targets, volume-based rewards, competitions or non-cash incentives
  • AFSL representatives and other personnel involved in providing financial product advice
  • Directors and officers responsible for remuneration governance, compliance and sales oversight
  • Corporations Act 2001 (Cth), Part 7.7A
  • Corporations Act 2001 (Cth), sections 963A, 963E and 963F
  • Corporations Act 2001 (Cth), section 180(1)
  • Life Insurance Framework conflicted remuneration reforms

AI-generated analysis. May contain errors or omissions — verify with the original ASIC source before acting. Full disclaimer.

What the ASIC said

Full Federal Court dismisses ASIC appeal against former Freedom Insurance director

Published by ASIC . Read the full notice at the source for the authoritative text.

Relevant Firm Types

InsuranceAll Firms
View Original on ASIC Back to Feed

Share this update